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The expression of a human melanoma-associate d an-
tigen, p97, in cultured melanoma cells was investigated 
using a modification of the Sternberger p e roxidase -an-
tiperoxidase (PAP) technique. Explant cultures of two 
skin melanomas were found to consist of a mixture of 
cells, some positive and some negative, for the expres-
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sion of p97. From two other melanomas two cell lines 
were newly established. All cells from these lines ex-
pressed d etectable p97 over a period up to 18 months. 
With the cell lines and the explant cultures we have 
initiated an investigation of the expression of p97 at t h e 
ultrastructural leve l, using the PAP technique. Antigen 
expression was d etected as a continuous, strongly 
staine d band at the cell s urface of the melanoma cells. 
Monoclonal antibodies to various tumor-associated cell sur-
face a ntigens of human m elanoma h ave been obtained [l-12]. 
One of these a ntigen s is p97, a glycoprotein of M ,.- 97,000 
[3,4,13]; the same antigen h as been called gp95 by Dippold et 
al [6]. Studies performed with immunoprecipitation [3,13), ab-
sorption [6], and binding techniques [ 4,13,14] have shown that 
p97 is strongly expr essed (50,000-400,000 molecules/ cell ) by 
abou t 50% of melanomas and more weakly (10,000-50,000 mol-
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ecules/cell) by other melanomas. Nonmelanoma tumors con-
tain less than 50,000 molecules of p97 per cell, and normal adult 
tissues express less than 10,000 molecules per cell [13,14; J. 
Brown, unpublished findings]. A partial amino acid sequence of 
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p97 has revealed that it is related to transferrin and, like 
transferrin, p97 can bind iron [15]. 
In a previous paper [16], Garriques et al reported that p97 
can be detected in frozen sections of melanoma biopsies using 
10 
FIG 1. Primary explant culture (27 days) of malignant melanoma a fter exposure to anti-p97 antibody 96.5. The melanoma cells are darkly 
stained while fibrob lasts (arrowheads) show no reaction. Bar= 100 flm . 
FIG 2. Same explant culture as in Fig 1 exposed to antibody 96.5. The different cell types of t he mixed cell popula tion in Fig 1 are clearly 
distinguishable. MP = macrophages, F =fibroblasts, both unstained; M =melanoma cell outlined by an electron-dense reaction product (arrows); 
N = nucleus. Bar= 10 fJ.m. 
FIG 3. Large lysosomes from macrophages demonstrated in Fig 2. Bar = 0.2 fJ.m. 
FIG 4. Mela nosomes in different degrees of deve lopment characteristic for melanoma cells shown in Fig 2. Bar = 0.2 flm . 
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a modification of t he Sternberger peroxidase-an tiperoxidase 
(PAP) technique [17]. B inding of a nti-p97 a ntibody was dem-
o n strated with 8 out of 10 primary skin m ela nomas, with 6 of 7 
metastatic m ela nomas, and with 2 of 2 nevi. No binding was 
detected with other skin tumors, including basal cell car cino-
mas, squamous cell carcinomas, a nd a leiomyosarcoma, nor was 
binding seen with normal adult skin, except for myoepithelial 
cells of sweat gla nds. According to t hat study [16], a nd in 
agreement with binding assays on Jiving cells [3] and immuno-
ch e mical studies [6,13], p97 is localized at t he cell smface. 
In this paper, we present m ore definitive evidence that p97 is 
strongly expressed at the cell surface , as revealed by an ultra-
structural investigation utilizing t he PAP techniq ue on cells 
th at were cultured from nodular m ela nomas of t he skin and 
fro m nodules arising in superficia l spreading m ela nomas. 
MATERIALS AND METHODS 
Cell Cultures 
Explant cul tures were derived from a nodu lar melanoma and from a 
nodu le wi thin a superficia l spreading melanoma. Similarly, 2 celt lines 
were established from another nodular melanoma and from a nodule 
within another superficial spreading melanoma. T hese cell lines were 
serially transferred in vitro for up to 75 passages during a period of 18 
mon ths. 
OUl· cell culture techniques have been described [18] and can be 
summarized as follows. Tumor biopsy material was dissected as free as 
possible from connective and necrotic tissue under a stereomicroscope. 
One-millimeter cubes were placed in plastic Petri dishes and covered 
with modified Eagle's minimal essential medium (4 X MEM) conta ining 
17% fetal calf serum, after which they were incubated at 37°C in a 
humidified atmosphere of 5% C02 in air; some of the tumor cubes were 
placed on glass coverslips, but were otherwise treated in the same way. 
Subcul tures were obta ined either by trypsinization of attached celts or 
by aspiration of floating cells. Cultures were regularly tested and found 
to be free of Mycoplasma. contamination. 
Immunocytochemical Staining 
The procedure for the immunocytochemical localization of p97 using 
the unlabeled antibody technique of Sternberger [17] has been de-
scribed previously fo r biopsy material [16]. The cul tures used in the 
present study were processed for immunoreactivity either before or 
after fixation in the Petri dishes with 1% glu taraldehyde for 30 min and 
washed with phosphate-buffered saline (PBS) containing 0.01 M lysine. 
In addition to anti-p97 antibody 96.5 [13] we used antibody Hll6-22.R 
as a control. This is a mouse H-2d anti-H-2• (IgG 2a) antibody (kindly 
provided by Prof. G. Hiimmerling, German Cancer Research Center, 
Heidelberg). These antibodies, goat antimouse IgG, and mouse PAP 
complex were dilu ted in a PBS solu tion containing 10% normal human 
serum and 3% goat serum. Monolayers were incubated with (specific) 
antibody 96.5 or with (control) antibody Hll6-22.R, both diluted 1:3 
from a pool of hybridoma cul ture supernatant in a final concentration 
of 0.166 !!g/ 50 /!1, followed by goat antimouse IgG (1:30), and finally by 
the mouse PAP complex (1:80) . Each incubation was for 30 min and 
after each step, specimens were washed in PBS. The sections were then 
incubated with freshly prepared 0.05% 3,3'-diaminobenzidine tetrahy-
drochloride in 0.05 M Tris buffer, pH 7.6, containing 0.01% H20 2 for 8 
min, in order to develop a visible reaction product, after which the 
preparations were postfixed with 1% OsO., for 20 min. 
Immunoelectron Microscopy 
Following immunocytochemical staining, cell monolayers in plastic 
dish es were fixed with 2.5% glu taraldehyde in 0.05 M sodium cacodylate 
buffer containing 50 mM KCl and 2.5 mM MgCb. Subsequently, the 
mon olayers were postfixed in 2% OsO., and stained with 1% aqueous 
uranyl acetate in situ. Following dehydration in a graded dilu tion series 
of ethanol, they were passed through metacrylic acid-2-hydroxypro-
pylester and embedded in Epon 812. After embedding, the cells were 
removed from the plastic dishes by quick freezing in liquid nitro-
gen. Ultrathin sections were cut' tangentially with a Reichert OmU3 
ultramicrotome. Both unstained sections and sections stained with lead 
citrate were examined with a Philips EM 400 electron microscope. 
RESULTS 
By immunohistochemistry of explant cultures colonies of 
mela noma cells could be distinguished from contaminating 
fibroblasts, m acrophages, a nd keratinocytes by staining th em 
with a n tibody 96.5 which is specific for p97 (Fig 1) . An unequiv-
ocal identification of t he cell types, however , was possible only 
by imm unoelectron microscopy (Fig 2). M acrophages, contain-
ing large Jysosomes (Figs 2, 3), and fibrob lasts were devoid of 
staining with anti-p97. Only the m elanoma cells, characterized 
by general ultrastructural featmes and by their specific mela-
nosomes, found in different degrees of development a nd m ela n-
ization (Fig 4), showed a dark staining which cover ed t he entire 
cell membra ne (Fig 2). The m ela noma cell lines were found 
·immunohistochemically to consist exclusively of cells that, fol-
lowing exposure to antibody 96.5, displayed a dark brown 
staining which covered the entire cells (Fig 5). This was also 
true after propagation of one of the cell lines in vitro for 18 
months. When the "control" antibody (H116-22.R) was used, 
only the melanosom es in m elanoma cells were darkly stained 
(Fig 6) . Using immunoelectron microscopy, th e overall cell 
a1·chitecture, a nd th e cell nuclei, m embran es, and organelles, 
including m elanosomes in different degr ees of melanization (Fig 
7), were well preserved and were C'>mparable in samples exposed 
to eit her anti-p97 or control antibody (Figs 8, 9). When th e 
anti-p97 antibody (96.5) was used, a n electron-dense reaction 
product was detected which appeared very closely associated 
with th e cell m embrane, where it was h eavily a nd evenly 
distributed (Fig 8a). At higher magnification, this product was 
found to consist of flo cculent, electron-dense aggr egates of 
granular deposits which covered th e total cell surface including 
the interdigitating microvilli (Fig 8b) . Cul tures processed to 
display in1munoreactivity before or after fixation were iden tical 
in appearance. No staining was seen in sections exposed to 
control antibody (Figs 9a,b). The cytoplasm a nd cytoplasmic 
organelles did not stain with eit her th e anti-p97 or the control 
antibody. 
DISCUSSION 
W e have investigated th e expression of a huma n m ela noma-
associated a ntigen, p97, as defined by a monoclonal mouse 
antibody, 96.5 [3,13], using a modification of th e Sternberger 
PAP technique [16,17]. The value of the PAP technique for 
u!trastructmal investigations of immunologic phenomena has 
been well documented in bullous diseases [19,20] and recently 
described fo r th e identification of Langerha ns cells [21] and 
Seza1·y cells [22]. Prima1·y cultmes a nd cell lines used in this 
study were derived from nodular melanomas and nodules luis-
ing in superficial spreading melanomas. The expla nt cultures 
consisted of a mixed population of cells, including m elanoma 
cells, fibroblasts, macrophages, a nd keratinocytes, while the cell 
lines comprised only melanoma cells which exclusively reacted 
· in all cultures with antibody 96.5. In all cases mela noma cells 
were identified by th eir contents of m ela nosomes as specific 
organ elles. 
The m ela noma cell cultures were chosen for an initial ultra-
structural study in which t he PAP technique [16,17,23] was 
used to visualize p97. With this approach , the antigen was 
detected at the cell surface as a continuous, electron-dense 
band, while no staining was detected in the cytoplasm . This 
observation agrees with findings made by light microscopy of 
sections from m elanoma biopsies [16]. In a separate series of 
experiments the cell lines were also characterized, besides by 
morphology, by cytometry, protein analysis, and cytogenetics. 
Tumorigenicity was tested by injecting the cell culture subcu-
taneously in nude mice. The an tigenic phenotype of the m ela-
noma remained stable in t he tumors that developed in t he sites 
of injection and in cells recultw-ed from th ese tumors (Tilgen et 
al, to be published). The most striking result is that all m ela-
nomas so far studied expressed the antigen p97 in the sam e 
way, irrespective of th e mode and time of propagation a nd 
irrespective of the techniques applied . The site of reaction was 
exclusively restricted to the cell surface. The localization of t he 
human mela noma-associated a n t igen p97 at the ul trastructw-al 
level by the immunoperoxidase method offers a better cha nce 
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for de termining th e exact tar get a nd h en ce th e s pecificity of t h e 
m onoclonal ant ibody 96.5. 
Howev er, further work is need e d in order to d etect a ny 
expression of p97 in the cytoplasm by exposing fixed a nd unfixed 
ce lls to a n t ibody a fter they h a ve been sectio n ed or by tr eating 
fixed cells with a lipid solven t to allow p enetr a tion of a ntibody 
in t o the cytoplasm. W e also pla n to use alternative immuno-
ch e mical procedw·es which give r eaction products wi th very 
low solubility, su ch a s la beling a ntibodies with ferrit in. This 
w ill allow us t o investigate wheth er p97 is eve nly distribute d or 
con centrate d in particular areas of t h e cell m e mbra n e. 
W e feel t h at ouT r esults a r e r eleva n t fo r clinical studies 
utilizing anti-p97 a nt ibodies as carriers of t umor localizing [24) 
a nd/ or destructive agen ts by providing direct evide nce tha t p97 
is e xpressed at t he cell surface, wher e i t should be easily 
accessible. In view of the r ecen t evide nce th a t p97 is r ela t ed t o 
tran sferrin [15], which is a soluble molecule tha t is not m em-
brane bound, it is a lso inter esting to n o t e th at p97 a ppear s to 
be a part of the cell m embra n e. 
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FIG 5. Cell Line (12 months, 50th passage) of malignant melanoma afte r exposUJ'e to anti-p97 ant ibody 96.5. All cells reveal a clark brown 
staining covering the total cell body. B ar = 50 Jtffi. 
F IG 6. Melanoma cell line as in Fig 5 after exposure to "control" antibody H116-22.R. No staining detectable. The dark melanosomes are 
indicated by the arrowhead. Bar = 50 fUll . 
FIG 7. Melanoma cell line exposed to antibody 96.5. The cell membt·ane is darkly stained by peroxidase precipi tates indicating the site of 
an tigen p97 (arrowheads ). The cytoplasm contains typical melanosomes (M) in various stages of development and melanization. M I = 
mitochondrion. Bar = 1 Jtlll. 
FIG 8. Melanoma cell line exposed to antibody 96.5. a, Melanoma cells are clearly outlined at their surface (arrowheads) by an electron-dense 
reaction product indicating deposition of the antibody. N = nuclei. B ar = 5 Jtm . b, Flocculent. electron-dense aggregates of granulal' deposits cover 
the cell membrane including interdigita ting microvilli. B ar= 1 Jtm. 
FIG 9. Melanoma cell line exposed to "contl'ol" antibody Hll6-22.R. The melanoma cells do not exhibit binding of the control antibody to the 
cell membrane (arrowheads ). N = nuclei, MV = microvilli, M = melanosomes in different degrees of melanization. Open arrowheads indicate 
attachment sites of melanoma cells. a, bar = 5 Jtm; b, bar = 1 Jtffi. 
